Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cleft Lip | 12 | 2022 | 33 | 5.860 |
Why?
|
| Cleft Palate | 7 | 2022 | 34 | 2.710 |
Why?
|
| Rhinoplasty | 5 | 2021 | 27 | 2.090 |
Why?
|
| Postoperative Complications | 5 | 2021 | 1615 | 1.350 |
Why?
|
| Surgical Flaps | 3 | 2019 | 120 | 1.200 |
Why?
|
| Cicatrix | 3 | 2021 | 60 | 1.090 |
Why?
|
| Goldenhar Syndrome | 2 | 2016 | 2 | 1.030 |
Why?
|
| Steroids | 2 | 2015 | 84 | 0.960 |
Why?
|
| Wound Healing | 2 | 2019 | 260 | 0.920 |
Why?
|
| Mandible | 2 | 2020 | 53 | 0.840 |
Why?
|
| Esthetics | 3 | 2019 | 18 | 0.830 |
Why?
|
| Dermoid Cyst | 1 | 2020 | 4 | 0.750 |
Why?
|
| Nose Neoplasms | 1 | 2020 | 25 | 0.730 |
Why?
|
| Mouth Abnormalities | 1 | 2020 | 2 | 0.730 |
Why?
|
| Tongue | 1 | 2020 | 20 | 0.720 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 18 | 0.720 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2019 | 7 | 0.670 |
Why?
|
| Scalp Dermatoses | 1 | 2019 | 13 | 0.670 |
Why?
|
| Skin Ulcer | 1 | 2019 | 19 | 0.670 |
Why?
|
| Facial Paralysis | 2 | 2021 | 25 | 0.640 |
Why?
|
| Facial Asymmetry | 1 | 2018 | 5 | 0.620 |
Why?
|
| Infant | 8 | 2021 | 2891 | 0.590 |
Why?
|
| Humans | 37 | 2022 | 68618 | 0.590 |
Why?
|
| Maxillofacial Prosthesis Implantation | 1 | 2016 | 1 | 0.570 |
Why?
|
| Maxillofacial Prosthesis | 1 | 2016 | 3 | 0.560 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 2016 | 14 | 0.550 |
Why?
|
| Lymphatic Abnormalities | 1 | 2016 | 2 | 0.550 |
Why?
|
| Sclerotherapy | 1 | 2016 | 10 | 0.550 |
Why?
|
| Veins | 1 | 2016 | 68 | 0.530 |
Why?
|
| Edema | 1 | 2016 | 66 | 0.530 |
Why?
|
| Vascular Malformations | 1 | 2016 | 19 | 0.530 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 438 | 0.530 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2015 | 2 | 0.510 |
Why?
|
| Keloid | 1 | 2015 | 10 | 0.500 |
Why?
|
| Triamcinolone | 1 | 2015 | 11 | 0.500 |
Why?
|
| Propranolol | 1 | 2015 | 103 | 0.500 |
Why?
|
| Antimetabolites | 1 | 2015 | 17 | 0.500 |
Why?
|
| Bacterial Infections | 1 | 2016 | 163 | 0.500 |
Why?
|
| Hemangioma | 1 | 2015 | 51 | 0.490 |
Why?
|
| Lip | 1 | 2014 | 12 | 0.490 |
Why?
|
| Fluorouracil | 1 | 2015 | 130 | 0.480 |
Why?
|
| Ear Auricle | 1 | 2014 | 1 | 0.470 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2014 | 15 | 0.470 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 150 | 0.460 |
Why?
|
| Ear | 1 | 2013 | 12 | 0.450 |
Why?
|
| World Health Organization | 1 | 2013 | 53 | 0.450 |
Why?
|
| Ear Diseases | 1 | 2014 | 37 | 0.450 |
Why?
|
| Ribs | 1 | 2013 | 25 | 0.450 |
Why?
|
| Congenital Abnormalities | 1 | 2013 | 42 | 0.450 |
Why?
|
| Cartilage | 1 | 2013 | 51 | 0.450 |
Why?
|
| Child, Preschool | 5 | 2019 | 3187 | 0.440 |
Why?
|
| Checklist | 1 | 2013 | 76 | 0.430 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 156 | 0.420 |
Why?
|
| Osteoma | 1 | 2012 | 6 | 0.420 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 23 | 0.410 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 3 | 0.400 |
Why?
|
| Child | 7 | 2022 | 6405 | 0.390 |
Why?
|
| Female | 16 | 2022 | 38074 | 0.380 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 168 | 0.350 |
Why?
|
| Thyroid Cartilage | 1 | 2008 | 2 | 0.320 |
Why?
|
| Cricoid Cartilage | 1 | 2008 | 10 | 0.320 |
Why?
|
| Tracheotomy | 1 | 2008 | 17 | 0.320 |
Why?
|
| Male | 14 | 2022 | 37321 | 0.320 |
Why?
|
| Endoscopy | 1 | 2012 | 464 | 0.320 |
Why?
|
| Retrospective Studies | 5 | 2022 | 7277 | 0.310 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 99 | 0.310 |
Why?
|
| Treatment Outcome | 6 | 2019 | 7029 | 0.300 |
Why?
|
| Rotation | 2 | 2019 | 58 | 0.290 |
Why?
|
| Laser Therapy | 2 | 2016 | 54 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 2324 | 0.250 |
Why?
|
| Hyperbaric Oxygenation | 2 | 2014 | 11 | 0.220 |
Why?
|
| El Salvador | 1 | 2022 | 8 | 0.210 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 3259 | 0.210 |
Why?
|
| Volunteers | 1 | 2022 | 30 | 0.210 |
Why?
|
| Scalp | 2 | 2020 | 47 | 0.210 |
Why?
|
| Nose | 2 | 2021 | 36 | 0.200 |
Why?
|
| Nasal Obstruction | 1 | 2021 | 34 | 0.190 |
Why?
|
| Aftercare | 1 | 2021 | 114 | 0.180 |
Why?
|
| Reoperation | 3 | 2021 | 467 | 0.180 |
Why?
|
| Eyelid Neoplasms | 1 | 2020 | 12 | 0.180 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2020 | 16 | 0.180 |
Why?
|
| Lichen Planus | 1 | 2020 | 17 | 0.180 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 49 | 0.170 |
Why?
|
| Hair | 1 | 2020 | 46 | 0.170 |
Why?
|
| Nasal Septum | 2 | 2021 | 16 | 0.170 |
Why?
|
| Adolescent | 4 | 2013 | 8912 | 0.170 |
Why?
|
| Alopecia | 1 | 2020 | 45 | 0.170 |
Why?
|
| Rare Diseases | 1 | 2019 | 41 | 0.170 |
Why?
|
| South Carolina | 2 | 2018 | 2752 | 0.160 |
Why?
|
| Syndrome | 1 | 2019 | 255 | 0.160 |
Why?
|
| Carcinoma | 1 | 2020 | 215 | 0.160 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 306 | 0.160 |
Why?
|
| Demography | 1 | 2019 | 279 | 0.160 |
Why?
|
| Triazoles | 1 | 2018 | 43 | 0.150 |
Why?
|
| Photography | 1 | 2018 | 37 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 446 | 0.150 |
Why?
|
| Glioma | 1 | 2018 | 140 | 0.140 |
Why?
|
| Temporomandibular Joint | 1 | 2016 | 18 | 0.140 |
Why?
|
| Polyethylene Terephthalates | 1 | 2016 | 29 | 0.140 |
Why?
|
| Osteogenesis, Distraction | 1 | 2016 | 13 | 0.140 |
Why?
|
| Silicones | 1 | 2016 | 32 | 0.140 |
Why?
|
| Polytetrafluoroethylene | 1 | 2016 | 55 | 0.140 |
Why?
|
| Polyethylenes | 1 | 2016 | 31 | 0.140 |
Why?
|
| Ecchymosis | 1 | 2016 | 1 | 0.140 |
Why?
|
| Lymphatic Vessels | 1 | 2016 | 5 | 0.140 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2016 | 17 | 0.140 |
Why?
|
| Plant Preparations | 1 | 2016 | 18 | 0.140 |
Why?
|
| Sildenafil Citrate | 1 | 2016 | 23 | 0.140 |
Why?
|
| Watchful Waiting | 1 | 2016 | 25 | 0.130 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2016 | 25 | 0.130 |
Why?
|
| Lidocaine | 1 | 2016 | 36 | 0.130 |
Why?
|
| Arteriovenous Malformations | 1 | 2016 | 34 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2019 | 2007 | 0.130 |
Why?
|
| Surgical Mesh | 1 | 2016 | 57 | 0.130 |
Why?
|
| Phytotherapy | 1 | 2016 | 53 | 0.130 |
Why?
|
| Osteotomy | 1 | 2016 | 46 | 0.130 |
Why?
|
| Ablation Techniques | 1 | 2016 | 33 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 424 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 79 | 0.130 |
Why?
|
| Hypotension | 1 | 2016 | 74 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 129 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1553 | 0.130 |
Why?
|
| Neuroectodermal Tumor, Melanotic | 1 | 2015 | 4 | 0.130 |
Why?
|
| Sirolimus | 1 | 2016 | 118 | 0.130 |
Why?
|
| Maxillary Neoplasms | 1 | 2015 | 12 | 0.130 |
Why?
|
| Glioblastoma | 1 | 2018 | 219 | 0.130 |
Why?
|
| Software | 1 | 2018 | 418 | 0.130 |
Why?
|
| Orbital Neoplasms | 1 | 2014 | 21 | 0.120 |
Why?
|
| Nasal Cartilages | 1 | 2014 | 2 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 186 | 0.120 |
Why?
|
| Biocompatible Materials | 1 | 2016 | 247 | 0.120 |
Why?
|
| Velopharyngeal Sphincter | 1 | 2014 | 7 | 0.120 |
Why?
|
| Dissection | 1 | 2014 | 29 | 0.120 |
Why?
|
| Adenoids | 1 | 2014 | 15 | 0.120 |
Why?
|
| Suture Techniques | 1 | 2014 | 75 | 0.120 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2014 | 14 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 371 | 0.120 |
Why?
|
| International Agencies | 1 | 2013 | 17 | 0.120 |
Why?
|
| Congenital Microtia | 1 | 2013 | 2 | 0.110 |
Why?
|
| Ear, External | 1 | 2013 | 14 | 0.110 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 150 | 0.110 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 138 | 0.110 |
Why?
|
| Otologic Surgical Procedures | 1 | 2013 | 23 | 0.110 |
Why?
|
| International Cooperation | 1 | 2013 | 88 | 0.110 |
Why?
|
| Thoracic Wall | 1 | 2013 | 20 | 0.110 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 145 | 0.110 |
Why?
|
| Global Health | 1 | 2013 | 136 | 0.110 |
Why?
|
| Hospitals, University | 1 | 2013 | 169 | 0.110 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 114 | 0.110 |
Why?
|
| Patient Selection | 1 | 2016 | 592 | 0.100 |
Why?
|
| Forehead | 1 | 2012 | 13 | 0.100 |
Why?
|
| Reference Values | 1 | 2013 | 579 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 514 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2018 | 2455 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 931 | 0.100 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 24 | 0.100 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2011 | 9 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 475 | 0.100 |
Why?
|
| Detergents | 1 | 2011 | 34 | 0.100 |
Why?
|
| Bandages | 1 | 2011 | 33 | 0.100 |
Why?
|
| Neuromuscular Agents | 1 | 2011 | 22 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2223 | 0.100 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2011 | 31 | 0.100 |
Why?
|
| Quality of Life | 1 | 2018 | 1515 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2279 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 166 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 234 | 0.080 |
Why?
|
| Adult | 4 | 2018 | 21403 | 0.080 |
Why?
|
| Kyphosis | 1 | 2008 | 18 | 0.080 |
Why?
|
| Trachea | 1 | 2008 | 48 | 0.080 |
Why?
|
| Scoliosis | 1 | 2008 | 42 | 0.080 |
Why?
|
| Labyrinth Diseases | 1 | 2007 | 3 | 0.080 |
Why?
|
| Semicircular Canals | 1 | 2007 | 9 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 1026 | 0.070 |
Why?
|
| Middle Aged | 3 | 2019 | 21147 | 0.070 |
Why?
|
| Sutures | 1 | 2021 | 32 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 1140 | 0.050 |
Why?
|
| Mucins | 1 | 2020 | 22 | 0.050 |
Why?
|
| Neck Dissection | 1 | 2020 | 55 | 0.040 |
Why?
|
| Dermoscopy | 1 | 2020 | 14 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 274 | 0.040 |
Why?
|
| Africa, Northern | 1 | 2018 | 3 | 0.040 |
Why?
|
| Middle East | 1 | 2018 | 17 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 54 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 109 | 0.040 |
Why?
|
| Developing Countries | 1 | 2018 | 106 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 138 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 706 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1603 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1745 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2014 | 89 | 0.030 |
Why?
|
| Adenoidectomy | 1 | 2014 | 51 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3705 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 242 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 14862 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 201 | 0.030 |
Why?
|
| Biopsy | 1 | 2014 | 540 | 0.030 |
Why?
|
| Palliative Care | 1 | 2014 | 271 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2358 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1070 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7367 | 0.020 |
Why?
|
| Palatal Neoplasms | 1 | 2007 | 10 | 0.020 |
Why?
|
| Temporal Bone | 1 | 2007 | 53 | 0.020 |
Why?
|
| Lymphoma | 1 | 2007 | 116 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.020 |
Why?
|
| Cochlear Implantation | 1 | 2007 | 99 | 0.020 |
Why?
|